Please wait while the formulary information is being retrieved.
PULMICORT FLEXHALER (budesonide)
- controller medication for asthma
180 mcg/actuation breath activated
- Inhale 1 puff (180 mcg) by inhalation route 2 times per day
90 mcg/actuation breath activated
- Inhale 2 puffs (180 mcg) by inhalation route 2 times per day
Default screening record
- Inhale 2 puffs (180 mcg) by inhalation route 2 times per day
- Inhale 1 puff (180 mcg) by inhalation route 2 times per day
- Inhale 2 puffs (360 mcg) by inhalation route 2 times per day
- Inhale 3 puffs (540 mcg) by inhalation route 2 times per day
- Inhale 4 puffs (720 mcg) by inhalation route 2 times per day
- None
Contraindicated
- boceprevir
- elvitegr-cobicist-emtric-tenof
- Incivek
- Kaletra
- Korlym
- lopinavir-ritonavir
- Mifeprex
- mifepristone
- Norvir
- Norvir Soft Gelatin
- ritonavir
- Stribild
- telaprevir
- Victrelis
Severe
Moderate
- amoxicil-clarithromy-lansopraz
- Avelox
- Avelox Abc Pack
- Avelox In Nacl (iso-osmotic)
- Biaxin
- Biaxin Xl
- Biaxin Xl Pak
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- clarithromycin
- Erythrocin
- erythromycin
- erythromycin-sulfisoxazole
- itraconazole
- ketoconazole
- Levaquin
- Levaquin In 5 % Dextrose
- levofloxacin
- levofloxacin in D5W
- moxifloxacin
- moxifloxacin in NaCl (iso-osm)
- norfloxacin
- Noroxin
- ofloxacin
- Omeclamox-pak
- omeprazole-clarith-amoxicillin
- Onmel
- Prevpac
- Sporanox
- Sporanox Pulsepak
- None
Contraindicated
- Herpes simplex infection
- Inactive tuberculosis
- Ocular herpes simplex
- Ocular hypertension
- Parasitic infection
- Pulmonary tuberculosis
- Varicella contact
- Varicella zoster virus infection
Severe
Moderate
- Cataracts
- Glaucoma
- Hypercortisolism
- Oropharyngeal candidiasis
- Osteopenia
- Osteoporosis
PULMICORT FLEXHALER (budesonide)
- controller medication for asthma
- None
- Allergic rhinitis
- Cough
- Dyspepsia
- Gastroenteritis
- Nasal congestion
- Oral candidiasis
- Pharyngitis
- Sinusitis
- Sore throat
- Upper respiratory infection
- Voice change
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Acute bacterial otitis media
- Bronchitis
- Bruising
- Dysgeusia
- Ecchymosis
- Fever
- General weakness
- Headache disorder
- Insomnia
- Nausea
- Pain
- Skin rash
- Syncope
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Adrenocortical insufficiency
- Anaphylaxis
- Angioedema
- Cataracts
- Drug-induced psychosis
- Eosinophilic granulomatosis with polyangiitis
- Glaucoma
- Hypercortisolism
- Immunosuppression
- Ocular hypertension
- Osteopenia
- Paradoxical bronchospasm
- Urticaria
Less Severe
- Aggressive behavior
- Arthralgia
- Contact dermatitis
- Depression
- Esophageal candidiasis
- Flu-like symptoms
- Irritability
- Nervousness
- Symptoms of anxiety
Contraindicated
None
Severe Precaution
Budesonide (Aerosol Pwder Inhaled)
Delivery device/dose form may not be appropriate <6 years. May reduce growth rate. Nebulized inhalation suspension preferred for age 1 to 6 years.
- 1 Day – 6 Years
- Delivery device/dose form may not be appropriate <6 years. May reduce growth rate. Nebulized inhalation suspension preferred for age 1 to 6 years.
Management or Monitoring Precaution
Budesonide (Aerosol Pwder_Misc)
May reduce growth rate; monitor growth and use lowest effective dose.
- 6 Years – 18 Years
- May reduce growth rate; monitor growth and use lowest effective dose.
Budesonide (inhal, Nasal)
- Severity Level:
2
- Additional Notes: Current evidence supports use of inhaled corticosteroids for asthma tx in preg
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Budesonide
Reported amount in breastmilk < 1% of maternal dose w/ inhalation.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Reported amount in breastmilk < 1% of maternal dose w/ inhalation. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Maintenance therapy for asthma | |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.909 | Unspecified asthma, uncomplicated |
| 0-9 | A-Z |
|---|---|
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.909 | Unspecified asthma, uncomplicated |
Formulary Reference Tool